PJP has also been described in association with the anti-tumor necrosis factor-α (TNFα) monoclonal antibody infliximab, which is broadly used in patients with autoimmune disease and inflammatory bowel disease [91,92,93,94]. This evidence concerns the gene TNF and inflammatory bowel disease.